Bristol Myers Squibb (BMY) EBT Margin (2009 - 2026)
Bristol Myers Squibb (BMY) reported EBT Margin of 31.50% for Q2 2026, up 17.05 percentage points from 14.45% a year earlier and up 3.30 percentage points from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) EBT Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Bristol Myers Squibb's EBT Margin came in at 24.21%, up 10.39 percentage points year-over-year; for FY2025, it was 19.36%, up 36.70 percentage points from FY2024.
- EBT Margin has a five-year change of +35.52 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at -17.35% in FY2024 (-36.10 pp), 18.75% in FY2023 (+2.04 pp), 16.71% in FY2022 (-0.75 pp) and 17.46% in FY2021 (+33.62 pp).
- The Q2 2026 figure ranks as the highest quarterly EBT Margin since Q1 2019.
- Year over year, EBT Margin has now increased in each of the last six quarters, with an average year-over-year change of +18.67 percentage points over the last eight quarters.
- The high point for year-over-year EBT Margin in five years was Q1 2025 (a gain of 123.58 percentage points); the low point was Q1 2024 (a drop of 121.49 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 28.20% (Q1 2026), 11.76% (Q4 2025) and 25.48% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,164.60 Bn | 1,133.19 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 624.86 Bn | 543.39 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 509.50 Bn | 482.61 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 366.62 Bn | 321.00 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 295.95 Bn | 259.94 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 260.20 Bn | 233.88 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 234.89 Bn | 190.29 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 192.98 Bn | 167.17 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 170.69 Bn | 117.33 Bn | 10.94 Bn | -4.34% |
| 10 | Bristol Myers Squibb | 124.50 Bn | 75.77 Bn | 9.25 Bn | 31.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.50% |
| Mar 31, 2026 | 28.20% |
| Dec 31, 2025 | 11.76% |
| Sep 30, 2025 | 25.48% |
| Jun 30, 2025 | 14.45% |
| Mar 31, 2025 | 26.52% |
| Dec 31, 2024 | 1.42% |
| Sep 30, 2024 | 14.09% |
| Jun 30, 2024 | 10.54% |
| Mar 31, 2024 | -97.06% |
| Dec 31, 2023 | 14.59% |
| Sep 30, 2023 | 19.49% |
| Jun 30, 2023 | 16.56% |
| Mar 31, 2023 | 24.43% |
| Dec 31, 2022 | 16.30% |
| Sep 30, 2022 | 19.69% |
| Jun 30, 2022 | 16.47% |
| Mar 31, 2022 | 14.48% |
| Dec 31, 2021 | 15.50% |
| Sep 30, 2021 | 18.56% |
API Access
Bristol Myers Squibb EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();